Weiya Ma’s long-term research interest is to advance the understanding of how substances involved in the inflammation process play a role in the development of chronic pain conditions.

Carl Ernst studies human behaviour and mood by identifying genes that may be involved in mental disorders.

Pierre Étienne is a psychiatrist in the geriatric psychiatry program of the Douglas Institute. He is interested in the early development of medication and in Alzheimer's Disease.

Eduardo Chachamovich’s work focuses mainly on social and clinical determinants of mental health in Aboriginal populations.

Marcelo Berlim is mainly interested in the study and treatment of depressive disorders with the use of state-of-the-art neuromodulation techniques.

Fabrice Jollant's research focuses on the cognitive and cerebral bases of vulnerability to suicide.

John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.

Rob Whitley examines barriers and facilitators to recovery within both health services and the wider socio-cultural environment.

Lalit Srivastava, has conducted research on schizophrenia and dopamine, a brain chemical implicated in its development.

Ashok Malla is an international leader in the development of programs for, and research in, early intervention in psychosis.